Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute ...

-- Fourth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate impact of subjects’ adherence to PoNS® therapy for gait improvement in Multiple Sclerosis --

NEWTOWN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the participation of Prue Plummer PhD, PT, Professor in the Department of Physical Therapy in the School of Health and Rehabilitation Sciences at the MGH Institute of Health Professions to its Therapeutic Experience Program (“TEP”). The MGH Institute of Health Professionals joins NYU Langone Health, the Shepherd Center, and Oregon Health & Science University as the fourth Center of Excellence in this company-sponsored open-label observational trial designed to evaluate the impact of subjects’ adherence to Portable Neuromodulation Stimulator (PoNS) therapy in patients with multiple sclerosis (“MS”).

“We are thrilled to have Dr. Plummer and the MGH Institute of Health Professions, one of the country’s preeminent health and rehabilitation institutions, as one of our Centers of Excellence for TEP,” said Antonella Favit-Van Pelt, M.D., Ph.D., Helius' Chief Medical Officer. “The purpose of our Therapeutic Experience Program is to gain insight about the functional outcome of PoNS therapy used with MS by treating patients in a real-world environment. The TEP study will provide information about PoNS therapy to key opinion leaders in MS management, providing an opportunity for early adopters of the technology. We are enthusiastic about Dr. Plummer’s participation in the study and her contribution to bringing new therapeutic options to MS patients.”

“At our School of Health and Rehabilitation Sciences center, we are keenly interested in the ways injuries to the brain can affect a person’s ability to walk, and how neurological rehabilitation can help improve gait recovery,” said Dr. Prue Plummer, Professor of Physical Therapy at MGH Institute of Health Professions. “The majority of patients with MS develop progressive gait impairment, which can worsen over a lifetime, and participation in TEP is an important step in evaluating how PoNS therapy can improve gait function and potentially address this treatment gap.”